SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001615774-15-002179
Filing Date
2015-08-12
Accepted
2015-08-12 16:11:05
Documents
11
Period of Report
2015-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q s101647_10q.htm 10-Q 540772
2 EXHIBIT 31.1 s101647_ex31-1.htm EX-31.1 9994
3 EXHIBIT 31.2 s101647_ex31-2.htm EX-31.2 9487
4 EXHIBIT 32.1 s101647_ex32-1.htm EX-32.1 4389
5 EXHIBIT 32.2 s101647_ex32-2.htm EX-32.2 4534
  Complete submission text file 0001615774-15-002179.txt   3372868

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE enum-20150630.xml EX-101.INS 487170
7 XBRL SCHEMA FILE enum-20150630.xsd EX-101.SCH 35793
8 XBRL CALCULATION FILE enum-20150630_cal.xml EX-101.CAL 46513
9 XBRL DEFINITION FILE enum-20150630_def.xml EX-101.DEF 169918
10 XBRL LABEL FILE enum-20150630_lab.xml EX-101.LAB 315210
11 XBRL PRESENTATION FILE enum-20150630_pre.xml EX-101.PRE 250950
Mailing Address 200 CAMBRIDGEPARK DRIVE, SUITE 2000 CAMBRIDGE MA 02140
Business Address 200 CAMBRIDGEPARK DRIVE, SUITE 2000 CAMBRIDGE MA 02140 (617) 674-1865
Enumeral Biomedical Holdings, Inc. (Filer) CIK: 0001561551 (see all company filings)

IRS No.: 990376434 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-55415 | Film No.: 151047141
SIC: 2834 Pharmaceutical Preparations